162 related articles for article (PubMed ID: 9531692)
1. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Ortner M; Lochs H
Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692
[No Abstract] [Full Text] [Related]
2. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
3. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Brand S; Wang TD; Schomacker KT; Poneros JM; Lauwers GY; Compton CC; Pedrosa MC; Nishioka NS
Gastrointest Endosc; 2002 Oct; 56(4):479-87. PubMed ID: 12297761
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
Gossner L; Stolte M; Sroka R; Rick K; May A; Hahn EG; Ell C
Gastroenterology; 1998 Mar; 114(3):448-55. PubMed ID: 9496934
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy.
Davila ML
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C
Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815
[TBL] [Abstract][Full Text] [Related]
7. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.
Barr H; Shepherd NA; Dix A; Roberts DJ; Tan WC; Krasner N
Lancet; 1996 Aug; 348(9027):584-5. PubMed ID: 8774572
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
Barr H
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256
[TBL] [Abstract][Full Text] [Related]
9. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Hinnen P; de Rooij FW; van Velthuysen ML; Edixhoven A; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 1998 Sep; 78(5):679-82. PubMed ID: 9744510
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Claydon PE; Ackroyd R
Dis Esophagus; 2004; 17(3):205-12. PubMed ID: 15361092
[TBL] [Abstract][Full Text] [Related]
11. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
[TBL] [Abstract][Full Text] [Related]
12. The role of photodynamic therapy in the esophagus.
Gross SA; Wolfsen HC
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M
Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus.
Lovat LB; Jamieson NF; Novelli MR; Mosse CA; Selvasekar C; Mackenzie GD; Thorpe SM; Bown SG
Gastrointest Endosc; 2005 Oct; 62(4):617-23. PubMed ID: 16185985
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study.
Javaid B; Watt P; Krasner N
Lasers Med Sci; 2002; 17(1):51-6. PubMed ID: 11845368
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.
Messmann H; Knüchel R; Bäumler W; Holstege A; Schölmerich J
Gastrointest Endosc; 1999 Jan; 49(1):97-101. PubMed ID: 9869731
[TBL] [Abstract][Full Text] [Related]
17. [Photodynamic therapy of dysplasia and early cancer of the esophagus].
Gossner L; Ell C
Leber Magen Darm; 1996 May; 26(3):132, 135-7. PubMed ID: 8709826
[TBL] [Abstract][Full Text] [Related]
18. Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium.
Wolfsen HC
Gastrointest Endosc; 2005 Oct; 62(4):499-503. PubMed ID: 16185960
[No Abstract] [Full Text] [Related]
19. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
20. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J
Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
